A new first-class treatise on the topic of vision health.
A small research study on patients with early Age-Related Macular Degeneration (AMD) showed improvement when taking a combination of acetyl-L-carnitine, omega-3 fatty acids, and coenzyme Q10.1
Nearly all of the subjects who took the supplements for one year showed significant improvement in visual acuity (Snellen Chart & ETDRS chart), foveal sensitivity and changes in the back of the eye (fundus: retina, optic disc, macula, fovea and posterior pole). Only 2% of these subjects had clinically significant worsening of their condition, while 17% of the control group who received a placebo got worse.
Drusen are yellow fat deposits under the retina associated with macular degeneration. The more drusen, the more likely a person will develop an advanced form of the disease. Study subjects who received the omega-3 fatty acids, acetyl-L-carnitine and coenzyme Q10 had statistically significant fewer drusen-covered areas of the eye versus the controls.
The researchers concluded that a combination of supplements that affect mitochondrial lipid metabolism may help stabilize early AMD. Acetyl-L-carnitine is an amino acid that helps the body produce energy. A metastudy2 found it may reduce LDL cholesterol (Low-density lipoprotein – the bad kind). This amino acid is made by the body but supplementation can be taken. Omega-3 fatty acids are found in cold water fish, flaxseed oil, dark leafy vegetables and eggs. A large body of research shows their benefits to the heart, circulation system, cholesterol levels – as well as positive effects on macular degeneration. CoQ10 helps cells metabolize food, enhances circulation and improves the heart. It is found in meat and vegetables, but it does not survive the cooking process.
Sigmaceutical is passionate about spreading health and strongly advocates the idea of strengthening the body’s defenses against sickness and disease through world class nutritional supplement formulations.
Try Sigmaceutical Lutein Vision Support today!